BG
Bollard Group’s Soleno Therapeutics SLNO Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $192K | Hold |
2,288
| – | – | ﹤0.01% | 181 |
|
2025
Q1 | $163K | Hold |
2,288
| – | – | ﹤0.01% | 168 |
|
2024
Q4 | $103K | Hold |
2,288
| – | – | ﹤0.01% | 183 |
|
2024
Q3 | $116K | Hold |
2,288
| – | – | ﹤0.01% | 194 |
|
2024
Q2 | $93K | Hold |
2,288
| – | – | ﹤0.01% | 201 |
|
2024
Q1 | $98K | Hold |
2,288
| – | – | ﹤0.01% | 195 |
|
2023
Q4 | $92K | Hold |
2,288
| – | – | ﹤0.01% | 193 |
|
2023
Q3 | $68K | Hold |
2,288
| – | – | ﹤0.01% | 204 |
|
2023
Q2 | $10K | Hold |
2,288
| – | – | ﹤0.01% | 305 |
|
2023
Q1 | $5K | Hold |
2,288
| – | – | ﹤0.01% | 269 |
|
2022
Q4 | $5K | Hold |
2,288
| – | – | ﹤0.01% | 262 |
|
2022
Q3 | $4K | Sell |
2,288
-32,034
| -93% | -$56K | ﹤0.01% | 269 |
|
2022
Q2 | $6K | Hold |
34,322
| – | – | ﹤0.01% | 273 |
|
2022
Q1 | $8K | Hold |
34,322
| – | – | ﹤0.01% | 408 |
|
2021
Q4 | $14K | Hold |
34,322
| – | – | ﹤0.01% | 406 |
|
2021
Q3 | $32K | Hold |
34,322
| – | – | ﹤0.01% | 373 |
|
2021
Q2 | $39K | Buy |
+34,322
| New | +$39K | ﹤0.01% | 363 |
|
2017
Q3 | – | Sell |
-192,217
| Closed | -$96K | – | 274 |
|
2017
Q2 | $96K | Sell |
192,217
-173,099
| -47% | -$86.5K | 0.01% | 206 |
|
2017
Q1 | $259K | Sell |
365,316
-17,310
| -5% | -$12.3K | 0.01% | 172 |
|
2016
Q4 | $310K | Sell |
382,626
-20,772
| -5% | -$16.8K | 0.02% | 166 |
|
2016
Q3 | $363K | Hold |
403,398
| – | – | 0.02% | 161 |
|
2016
Q2 | $468K | Hold |
403,398
| – | – | 0.03% | 158 |
|
2016
Q1 | $480K | Hold |
403,398
| – | – | 0.04% | 153 |
|
2015
Q4 | $746K | Hold |
403,398
| – | – | 0.06% | 142 |
|
2015
Q3 | $851K | Buy |
403,398
+46,216
| +13% | +$97.5K | 0.07% | 151 |
|
2015
Q2 | $1M | Hold |
357,182
| – | – | 0.08% | 139 |
|
2015
Q1 | $2.29M | Buy |
357,182
+13,407
| +4% | +$85.8K | 0.17% | 84 |
|
2014
Q4 | $512K | Buy |
+343,775
| New | +$512K | 0.05% | 150 |
|